SOX9 and colorectal carcinoma: Most critically, survival analyses based on expression levels of SOX9 and Gal-1 demonstrate that CRC patients with SOX9high/Gal-1high expression have a significantly shorter survival compared with patients with SOX9low/Gal-1low expression (Figure 6E and Supplementary Figure S5).